These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34036520)

  • 1. Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations.
    Paiva-Santos AC; Silva AL; Guerra C; Peixoto D; Pereira-Silva M; Zeinali M; Mascarenhas-Melo F; Castro R; Veiga F
    Pharm Res; 2021 Jun; 38(6):947-970. PubMed ID: 34036520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking the potential of cosmetic dermal delivery with ethosomes: A comprehensive review.
    Abu-Huwaij R; Zidan AN
    J Cosmet Dermatol; 2024 Jan; 23(1):17-26. PubMed ID: 37393573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.
    Rao Y; Zheng F; Zhang X; Gao J; Liang W
    AAPS PharmSciTech; 2008; 9(3):860-5. PubMed ID: 18649143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.
    Yang L; Wu L; Wu D; Shi D; Wang T; Zhu X
    Int J Nanomedicine; 2017; 12():3357-3364. PubMed ID: 28490875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization.
    Jafari A; Daneshamouz S; Ghasemiyeh P; Mohammadi-Samani S
    J Liposome Res; 2023 Mar; 33(1):34-52. PubMed ID: 35695714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethosomes for Dermal Administration of Natural Active Molecules.
    Natsheh H; Vettorato E; Touitou E
    Curr Pharm Des; 2019; 25(21):2338-2348. PubMed ID: 31333087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis.
    Wang P; Hong S; Cao C; Guo S; Wang C; Chen X; Wang X; Song P; Li N; Xu R
    J Nanobiotechnology; 2024 Sep; 22(1):584. PubMed ID: 39334378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
    Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
    Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical nanocarriers for management of Rheumatoid Arthritis: A review.
    Anita C; Munira M; Mural Q; Shaily L
    Biomed Pharmacother; 2021 Sep; 141():111880. PubMed ID: 34328101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
    Sharma G; Goyal H; Thakur K; Raza K; Katare OP
    Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery.
    Madhavi N; Sudhakar B; Reddy KVNS; Ratna JV
    Drug Dev Ind Pharm; 2019 Apr; 45(4):611-628. PubMed ID: 30712433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
    Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
    Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Developments in the Principles, Modification and Application Prospects of Functionalized Ethosomes for Topical Delivery.
    Lu J; Guo T; Fan Y; Li Z; He Z; Yin S; Feng N
    Curr Drug Deliv; 2021; 18(5):570-582. PubMed ID: 32851961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug.
    Bodade SS; Shaikh KS; Kamble MS; Chaudhari PD
    Drug Deliv; 2013; 20(1):40-6. PubMed ID: 23311652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
    Sala M; Diab R; Elaissari A; Fessi H
    Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.
    Jain S; Tiwary AK; Sapra B; Jain NK
    AAPS PharmSciTech; 2007 Dec; 8(4):E111. PubMed ID: 18181532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of the effect of ethanol and surfactant in vesicular carriers on Lamivudine permeation through the skin.
    Sudhakar K; Mishra V; Jain S; Rompicherla NC; Malviya N; Tambuwala MM
    Int J Pharm; 2021 Dec; 610():121226. PubMed ID: 34710540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethosomes: new prospects in transdermal delivery.
    Godin B; Touitou E
    Crit Rev Ther Drug Carrier Syst; 2003; 20(1):63-102. PubMed ID: 12911264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.